ID   CATIN_HUMAN             Reviewed;         758 AA.
AC   Q8WUQ7; A6NNA9; A9UL12; O75229; Q7LE08; Q9BTA6; Q9Y5A4;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 3.
DT   28-JUN-2023, entry version 166.
DE   RecName: Full=Splicing factor Cactin {ECO:0000305};
DE   AltName: Full=Renal carcinoma antigen NY-REN-24;
GN   Name=CACTIN; Synonyms=C19orf29;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Cai Y., Yan Y.;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 123-758.
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 69-758.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 469-758 (ISOFORM 1).
RC   TISSUE=Cervix, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 534-758 (ISOFORM 1), AND IDENTIFICATION AS A
RP   RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SPLICEOSOMAL
RP   C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/s1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [7]
RP   FUNCTION, INTERACTION WITH NFKBIL1, AND SUBCELLULAR LOCATION.
RX   PubMed=20829348; DOI=10.1074/jbc.m110.139113;
RA   Atzei P., Gargan S., Curran N., Moynagh P.N.;
RT   "Cactin targets the MHC class III protein IkappaB-like (IkappaBL) and
RT   inhibits NF-kappaB and interferon-regulatory factor signaling pathways.";
RL   J. Biol. Chem. 285:36804-36817(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-476, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-559, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION BY TNFA, AND INTERACTION WITH
RP   TRIM39.
RX   PubMed=26363554; DOI=10.1007/s00018-015-2040-x;
RA   Suzuki M., Watanabe M., Nakamaru Y., Takagi D., Takahashi H., Fukuda S.,
RA   Hatakeyama S.;
RT   "TRIM39 negatively regulates the NFkappaB-mediated signaling pathway
RT   through stabilization of Cactin.";
RL   Cell. Mol. Life Sci. 73:1085-1101(2016).
RN   [11]
RP   FUNCTION, INTERACTION WITH SRRM2 AND DHX8, AND SUBCELLULAR LOCATION.
RX   PubMed=28062851; DOI=10.1242/jcs.194068;
RA   Zanini I.M., Soneson C., Lorenzi L.E., Azzalin C.M.;
RT   "Human cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA
RT   splicing and sister chromatid cohesion.";
RL   J. Cell Sci. 130:767-778(2017).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-469 AND LYS-484, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [13]
RP   INTERACTION WITH SDE2 AND SF3B1.
RX   PubMed=34365507; DOI=10.1093/nar/gkab647;
RA   Floro J., Dai A., Metzger A., Mora-Martin A., Ganem N.J., Cifuentes D.,
RA   Wu C.S., Dalal J., Lyons S.M., Labadorf A., Flynn R.L.;
RT   "SDE2 is an essential gene required for ribosome biogenesis and the
RT   regulation of alternative splicing.";
RL   Nucleic Acids Res. 49:9424-9443(2021).
CC   -!- FUNCTION: Plays a role in pre-mRNA splicing by facilitating excision of
CC       a subset of introns (PubMed:28062851). Required for the splicing of
CC       CDCA5/Sororin, a regulator of sister chromatid cohesion
CC       (PubMed:28062851). Involved in the regulation of innate immune response
CC       (PubMed:20829348). Acts as negative regulator of Toll-like receptor,
CC       interferon-regulatory factor (IRF) and canonical NF-kappa-B signaling
CC       pathways (PubMed:20829348, PubMed:26363554). Contributes to the
CC       regulation of transcriptional activation of NF-kappa-B target genes in
CC       response to endogenous pro-inflammatory stimuli (PubMed:20829348,
CC       PubMed:26363554). {ECO:0000269|PubMed:20829348,
CC       ECO:0000269|PubMed:26363554, ECO:0000269|PubMed:28062851}.
CC   -!- SUBUNIT: Interacts (via N-terminal domain) with NFKBIL1; the
CC       interaction occurs in a pro-inflammatory-independent manner
CC       (PubMed:20829348). Does not interact with RELA NF-kappa-B subunit
CC       (PubMed:20829348). Identified in the spliceosome C complex
CC       (PubMed:11991638). Interacts with SF3B1 (PubMed:34365507). Interacts
CC       with SDE2 (PubMed:34365507). Interacts with SRRM2 (PubMed:28062851).
CC       Interacts with DHX8 (PubMed:28062851). Interacts with isoform 2 of
CC       TRIM39 (via domain B box-type) (PubMed:26363554).
CC       {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:20829348,
CC       ECO:0000269|PubMed:26363554, ECO:0000269|PubMed:28062851,
CC       ECO:0000269|PubMed:34365507}.
CC   -!- INTERACTION:
CC       Q8WUQ7; P49760: CLK2; NbExp=3; IntAct=EBI-348479, EBI-750020;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20829348,
CC       ECO:0000269|PubMed:26363554, ECO:0000269|PubMed:28062851}. Cytoplasm,
CC       cytosol {ECO:0000269|PubMed:26363554}. Note=Nuclear localization with a
CC       speckled expression pattern in some cells. Colocalizes with NFKBIL1 in
CC       the nucleus. {ECO:0000269|PubMed:20829348}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WUQ7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WUQ7-2; Sequence=VSP_017856;
CC   -!- INDUCTION: Up-regulated by TNF-alpha/TNFA (at protein level).
CC       {ECO:0000269|PubMed:26363554}.
CC   -!- MISCELLANEOUS: Antigen recognized by autologous antibody in patients
CC       with renal-cell carcinoma.
CC   -!- MISCELLANEOUS: [Isoform 1]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay.
CC   -!- SIMILARITY: Belongs to the CACTIN family. {ECO:0000305}.
CC   -!- CAUTION: An ORF (C19orf029 OS) has been described in the opposite
CC       strand of the C-terminus of this gene. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC24305.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAC32903.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAD42868.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH04262.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=EAW69298.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY917150; AAX84551.1; -; mRNA.
DR   EMBL; AC005175; AAC24305.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC005542; AAC32903.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF155102; AAD42868.1; ALT_FRAME; mRNA.
DR   EMBL; CH471139; EAW69298.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; BC004262; AAH04262.1; ALT_INIT; mRNA.
DR   EMBL; BC019848; AAH19848.1; -; mRNA.
DR   CCDS; CCDS45920.1; -. [Q8WUQ7-1]
DR   PIR; T02672; T02672.
DR   RefSeq; NP_001074012.1; NM_001080543.1. [Q8WUQ7-1]
DR   RefSeq; NP_067054.1; NM_021231.1. [Q8WUQ7-1]
DR   PDB; 6QDV; EM; 3.30 A; F=637-758.
DR   PDB; 7W5A; EM; 3.60 A; Z=1-758.
DR   PDB; 7W5B; EM; 4.30 A; Z=1-758.
DR   PDBsum; 6QDV; -.
DR   PDBsum; 7W5A; -.
DR   PDBsum; 7W5B; -.
DR   AlphaFoldDB; Q8WUQ7; -.
DR   SMR; Q8WUQ7; -.
DR   BioGRID; 121836; 121.
DR   CORUM; Q8WUQ7; -.
DR   IntAct; Q8WUQ7; 26.
DR   MINT; Q8WUQ7; -.
DR   STRING; 9606.ENSP00000415078; -.
DR   iPTMnet; Q8WUQ7; -.
DR   MetOSite; Q8WUQ7; -.
DR   PhosphoSitePlus; Q8WUQ7; -.
DR   BioMuta; CACTIN; -.
DR   DMDM; 322510133; -.
DR   EPD; Q8WUQ7; -.
DR   jPOST; Q8WUQ7; -.
DR   MassIVE; Q8WUQ7; -.
DR   MaxQB; Q8WUQ7; -.
DR   PaxDb; Q8WUQ7; -.
DR   PeptideAtlas; Q8WUQ7; -.
DR   ProteomicsDB; 74701; -. [Q8WUQ7-1]
DR   ProteomicsDB; 74702; -. [Q8WUQ7-2]
DR   Antibodypedia; 52584; 106 antibodies from 19 providers.
DR   DNASU; 58509; -.
DR   Ensembl; ENST00000221899.7; ENSP00000221899.4; ENSG00000105298.14. [Q8WUQ7-1]
DR   Ensembl; ENST00000248420.9; ENSP00000248420.5; ENSG00000105298.14. [Q8WUQ7-1]
DR   Ensembl; ENST00000429344.7; ENSP00000415078.1; ENSG00000105298.14. [Q8WUQ7-1]
DR   Ensembl; ENST00000585942.5; ENSP00000465751.1; ENSG00000105298.14. [Q8WUQ7-1]
DR   GeneID; 58509; -.
DR   KEGG; hsa:58509; -.
DR   MANE-Select; ENST00000429344.7; ENSP00000415078.1; NM_001080543.2; NP_001074012.1.
DR   UCSC; uc002lyh.4; human. [Q8WUQ7-1]
DR   AGR; HGNC:29938; -.
DR   CTD; 58509; -.
DR   DisGeNET; 58509; -.
DR   GeneCards; CACTIN; -.
DR   HGNC; HGNC:29938; CACTIN.
DR   HPA; ENSG00000105298; Low tissue specificity.
DR   MIM; 618536; gene.
DR   neXtProt; NX_Q8WUQ7; -.
DR   OpenTargets; ENSG00000105298; -.
DR   PharmGKB; PA134932683; -.
DR   VEuPathDB; HostDB:ENSG00000105298; -.
DR   eggNOG; KOG2370; Eukaryota.
DR   GeneTree; ENSGT00950000183102; -.
DR   HOGENOM; CLU_011759_0_0_1; -.
DR   InParanoid; Q8WUQ7; -.
DR   OMA; HIDFWND; -.
DR   OrthoDB; 558574at2759; -.
DR   PhylomeDB; Q8WUQ7; -.
DR   TreeFam; TF300906; -.
DR   PathwayCommons; Q8WUQ7; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SignaLink; Q8WUQ7; -.
DR   BioGRID-ORCS; 58509; 739 hits in 1163 CRISPR screens.
DR   ChiTaRS; CACTIN; human.
DR   GeneWiki; C19orf29; -.
DR   GenomeRNAi; 58509; -.
DR   Pharos; Q8WUQ7; Tbio.
DR   PRO; PR:Q8WUQ7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8WUQ7; protein.
DR   Bgee; ENSG00000105298; Expressed in sural nerve and 190 other tissues.
DR   ExpressionAtlas; Q8WUQ7; baseline and differential.
DR   Genevisible; Q8WUQ7; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0045292; P:mRNA cis splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IMP:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0045824; P:negative regulation of innate immune response; IBA:GO_Central.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; IMP:UniProtKB.
DR   GO; GO:0032717; P:negative regulation of interleukin-8 production; IDA:UniProtKB.
DR   GO; GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:UniProtKB.
DR   GO; GO:0060339; P:negative regulation of type I interferon-mediated signaling pathway; IMP:UniProtKB.
DR   InterPro; IPR019134; Cactin_C.
DR   InterPro; IPR018816; Cactin_central.
DR   PANTHER; PTHR21737:SF6; CACTIN; 1.
DR   PANTHER; PTHR21737; POLYGLUTAMINE BINDING PROTEIN 1/MARVEL MEMBRANE-ASSOCIATING DOMAIN CONTAINING 3; 1.
DR   Pfam; PF10312; Cactin_mid; 1.
DR   Pfam; PF09732; CactinC_cactus; 1.
DR   SMART; SM01050; CactinC_cactus; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Cytoplasm;
KW   Developmental protein; Immunity; Innate immunity; Isopeptide bond;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Spliceosome; Ubl conjugation.
FT   CHAIN           1..758
FT                   /note="Splicing factor Cactin"
FT                   /id="PRO_0000231617"
FT   REGION          1..140
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          155..181
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          477..536
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          135..185
FT                   /evidence="ECO:0000255"
FT   COILED          225..277
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        10..53
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        54..69
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        76..99
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        109..140
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        521..536
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9CS00"
FT   MOD_RES         476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         559
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   CROSSLNK        469
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        484
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         758
FT                   /note="R -> RPGPCWRPIRHCRRDPLWTPTLCRDWPPTHPVLAGGVHFPAAGIPPP
FT                   GLLTGPWSMRPVTPSFAHIRTVAPSHSPFSGQEGRGPHGCHSPGRSGPAGRLVLQHPTG
FT                   TSPTEAKRKVPPGPPEGHPTSPVTSPRPPTAPPRHPASSGNSSVCFSKKTCRWEKKSFV
FT                   LMELAYWQDRMFF (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_017856"
FT   CONFLICT        499
FT                   /note="A -> V (in Ref. 4; AAH19848)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   758 AA;  88702 MW;  F540F151EB96BEFB CRC64;
     MGRDTRSRSR SAGRRGRRRQ SQSGSRSRSR SHGRRNRRRR EDEGRRRRRR RSRERRSDSE
     EERWQRSGMR SRSPPRPKWH SRDGSSQSDS GEEQSRGQWA RRRRRARSWS PSSSASSSAS
     PGRSQSPRAA AAALSQQQSL QERLRLREER KQQEELMKAF ETPEEKRARR LAKKEAKERK
     KREKMGWGEE YMGYTNTDNP FGDNNLLGTF IWNKALEKKG ISHLEEKELK ERNKRIQEDN
     RLELQKVKQL RLEREREKAM REQELEMLQR EKEAEHFKTW EEQEDNFHLQ QAKLRSKIRI
     RDGRAKPIDL LAKYISAEDD DLAVEMHEPY TFLNGLTVAD MEDLLEDIQV YMELEQGKNA
     DFWRDMTTIT EDEISKLRKL EASGKGPGER REGVNASVSS DVQSVFKGKT YNQLQVIFQG
     IEGKIRAGGP NLDMGYWESL LQQLRAHMAR ARLRERHQDV LRQKLYKLKQ EQGVESEPLF
     PILKQEPQSP SRSLEPEDAA PTPPGPSSEG GPAEAEVDGA TPTEGDGDGD GEGEGEGEAV
     LMEEDLIQQS LDDYDAGRYS PRLLTAHELP LDAHVLEPDE DLQRLQLSRQ QLQVTGDASE
     SAEDIFFRRA KEGMGQDEAQ FSVEMPLTGK AYLWADKYRP RKPRFFNRVH TGFEWNKYNQ
     THYDFDNPPP KIVQGYKFNI FYPDLIDKRS TPEYFLEACA DNKDFAILRF HAGPPYEDIA
     FKIVNREWEY SHRHGFRCQF ANGIFQLWFH FKRYRYRR
//
